Covaxin receives approval for emergency use in 12-18 years old children
Covaxin is formulated uniquely such that the same dosage can be administered to adults and children
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
China CanSinoBIO’s vaccine 57.5 per cent effective against COVID in phase-III trial: Study
The single-shot Ad5-nCoV vaccine, which CanSinoBIO co-developed with the Chinese military-backed Beijing Institute of…
DCGI seeks more data from SII over its application seeking emergency authorisation for Covovax
Serum Institute of India (SII) had sent an application to the DCGI in October for the grant of market authorisation of Covovax for…
6th Nutrition and Wellness Awards 2021 felicitates nutraceutical brands
The brands that graced the event were from various domains of the industry such as research and development, manufacturing,…
Biocon Biologics initiates clinical study for Itolizumab in Lupus Nephritis
Equalise is a phase-Ib open-label, proof-of-concept clinical study currently studying Lupus Nephritis patients in the Part B…
University of Oxford study supports use of Vaxzevria as third-dose booster against Omicron
Neutralising anti-body levels against Omicron following a third-dose boost of Vaxzevria were broadly similar to levels achieved…
UK government to purchase additional 1.75 million courses of Molnupiravir
With this additional procurement agreement, which follows a previously announced agreement for 480,000 courses of treatment, the…
Serum waives AstraZeneca shot indemnity for refugee programme
The news comes days after Reuters reported that tens of millions of migrants may be denied COVID-19 vaccines from the…
Valneva says Chikungunya vaccine phase-III trial has met primary endpoint
In August, after Valneva gave a positive update on the phase-III trial
US FDA authorises first oral antiviral to treat COVID
The antiviral, Paxlovid, is not authorised for the pre-exposure or post-exposure prevention of COVID-19 or for initiation of…
10th Indian Pharma Expo held in Delhi
The event helped the industry to understand the challenges and changes, unique ideas, innovation and execution, cost-effective…
Zydus Cadila receives tentative approval from US FDA for Pimavanserin tablets
The tablets are used to treat the symptoms of a certain mental/mood disorder (psychosis) that might occur with Parkinson's disease
Government approves PLI scheme to boost domestic API production: Dr Mansukh Mandaviya
The total outlay of the scheme is Rs 6,940 crores and financial incentive under the scheme is provided to the selected…
US FDA approves expanded use of Amgen’s psoriasis drug
The drug is already approved for three indications, including to treat patients with moderate-to-severe plaque psoriasis and…
Sputnik V due to submit vaccine data to WHO this month
Moscow rushed to approve the shot for domestic use last year and it has been exported to countries around the world, but it has…
Piramal Pharma invests Rs 101.77 crores in Hyderabad-based Yapan Bio
The Mumbai-based company has acquired a 27.78 per cent stake in Yapan as a result of the investment
Bharat Biotech seeks nod for trial of intranasal vaccine as booster dose
An intranasal vaccine as a booster dose would be easier to administer in mass vaccination campaigns and has the potential to…
WHO lists 10th COVID-19 vaccine for emergency use: Nuvaxovid
The new vaccine was developed by Novavax and the Coalition for Epidemic Preparedness Innovations (CEPI), and is the originator…
MSN Pharmaceuticals Inc completes its maiden US FDA audit with zero observations
The state-of-the-art finished dosages facility was established to bolster MSN Group’s product portfolio as well as Contract…
Vaccine delivery under Quad framework to commence in early 2022: Shringla
In March, leaders of the Quad, comprising India, the US, Japan and Australia, launched the Quad Vaccine Partnership to help…